For more than 20 years, Illumina has aspired to improve human health by unlocking the power
of the genome. Now, with more than 3400 patents worldwide and our sequencing-by-synthesis
technology being used to generate over 90% of the world’s sequencing data, we are just
beginning to discover the true impact of genomics in areas we touch, including oncology,
reproductive health, genetic disease, agriculture, microbiology, and beyond.
Additional Info
We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth?
NoIncluded in the Export Interest Directory?
No